A Russian University has successfully completed human trials of the first Covid-19 vaccine on volunteers, claimed local media reports.
The human trials of the world's first Covid-19 vaccine have been completed at Sechenov First Moscow State Medical University, reported Sputnik News quoting Vadim Tarasov, the director of the Institute for Translational Medicine and Biotechnology.
The university began human clinical trials on the Covid-19 vaccine produced by Russia's Gamelei Institute of Epidemiology and Microbiology on June 18.
"Sechenov University has successfully completed tests on volunteers of the world's first vaccine against coronavirus," Tarasov told Sputnik news.
He went on to add that the first group of volunteers will be discharged on Wednesday and the second batch will be out on July 20.
Alexander Lukashev, the director of the Institute of Medical Parasitology, tropical and vector-borne diseases at the university, told Sputnik News that the objective of this stage of the study was to show the vaccine's safety on humans — something that has been successfully achieved.
While the report did not note anything the time when the vaccine will be released for public, Lukashev told the news outlet that further vaccine development plan is already being determined by the developer's strategy.
Tarasov concluded saying that the university worked with the vaccine, right from the preclinical studies and protocol development.
Meanwhile, Chief researcher Elena Smolyarchuk, who is head of the Center for Clinical Research on Medications at the university, also confirmed that human trials for the vaccine have been completed.
